SURMODICS INC (SRDX)
2025-06-30 | 2025-03-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenue | 29,567 | 28,085 | 29,922 | |
| Selling, general and administrative | 17,750 | 15,045 | 15,174 | |
| Research and development | 7,573 | 8,367 | 8,941 | |
| Product costs | 8,576 | 7,830 | 7,425 | |
| Acquired intangible asset amortization | 910 | 853 | 863 | |
| Total operating costs and expenses | 34,809 | 32,095 | 32,403 | |
| Operating (loss) income | -5,242 | -4,010 | -2,481 | |
| Investment income, net | 265 | 253 | 387 | |
| Interest expense, net | 864 | 855 | 882 | |
| Foreign exchange loss | -88 | -70 | 32 | |
| Other expense, net | -687 | -672 | -463 | |
| (loss) income before income taxes | -5,929 | -4,682 | -2,944 | |
| Income tax benefit (expense) | -611 | 527 | 700 | |
| Net (loss) income | -5,318 | -5,209 | -3,651 | |
| Earnings per share, basic | -0.37 | -0.36 | -0.26 | |
| Earnings per share, diluted | -0.37 | -0.36 | -0.26 | |
| Weighted average number of shares outstanding, basic | 14,281,000 | 14,278,000 | 14,231,000 | |
| Weighted average number of shares outstanding, diluted | 14,281,000 | 14,278,000 | 14,231,000 | |